At the same time, the phase I/II trial for HCC showed the probabilities of increased levels of serum AST and ALT were observed in 36% (9/25) and 24% (6/25) and those of more than grade 3 of AST and ALT were 12% and 4%, respectively [47]. Here, GPT is linked to hepatocellular carcinoma.